Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have agreed to take part in the research and have signed a consent form
- You are able to understand what the study is about and what taking part involves
- You are covered by French social security or an equivalent scheme
- You have been diagnosed with ALS (Amyotrophic Lateral Sclerosis), either with no family history of the disease or with at least one other family member also affected
- You do not have ALS yourself, but a close family member has or had ALS, carries a known gene change linked to ALS, and has agreed to genetic testing
- You have a motor (movement-related) condition, which may include: motor neuropathy, myopathy, myositis, spastic paraplegia, cramp/fasciculation syndrome, chronic inflammatory nerve disease, somatization disorder, anterior spinal artery syndrome, encephalitis, myelitis, peroneal neuropathy, cervical spine disease with nerve involvement, spinocerebellar ataxia, Kennedy disease, spinal muscular atrophy, or hereditary distal motor neuropathy (confirm with trial site)
- You are a carer or close companion of someone with ALS or another motor condition who is being treated at the ALS centre or neurology department at Pitié-Salpêtrière Hospital in Paris
Who may not be able to join:
- You are currently under a legal protection order, such as guardianship or a similar arrangement
- You do not wish to take part in the study
- Your doctor feels your current health condition makes it unsafe or unsuitable to have a blood draw or participate in research
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: François SALACHAS, MD, APHP, Hôpital de la Salpêtrière, INSERM U1127, ICM
Phone: +331 42 16 24 72
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measure of transcriptome differences between the ALS group and the 3 other groups of participants.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.